34 results
8-K
EX-4.1
QLGN
Qualigen Therapeutics Inc
22 Dec 22
Entry into a Material Definitive Agreement
4:15pm
S-3
EX-4.28
QLGN
Qualigen Therapeutics Inc
Shelf registration
29 Jul 22
5:36pm
S-3
EX-4.29
QLGN
Qualigen Therapeutics Inc
Shelf registration
29 Jul 22
5:36pm
10-Q
2022 Q1
EX-4.15
QLGN
Qualigen Therapeutics Inc
Quarterly report
13 May 22
6:10am
10-KT
EX-4.13
kgmjawye7ufmt931k
31 Mar 21
Annual report (with FYE transition)
4:33pm
10-KT
EX-4.3
7r822jpt8ck56m2
31 Mar 21
Annual report (with FYE transition)
4:33pm
10-KT
EX-4.14
g7dqp5ji 27sm
31 Mar 21
Annual report (with FYE transition)
4:33pm
S-8
EX-4.8
mpsd1jgg0h ade
2 Oct 20
Registration of securities for employees
4:54pm
8-K
EX-4.1
e67mhdtnuwvl
24 Jul 19
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-4.1
mxgzkudl1 5aen
7 May 18
Entry into a Material Definitive Agreement
6:03am
8-K
EX-4.1
9szgsu0w3g9ce1e7521j
22 Mar 18
Material Modifications to Rights of Security Holders
12:00am
8-K
EX-4.1
tdfq2x2du5p7roqjww
4 Oct 17
Ritter Pharmaceuticals, Inc. Prices $23,000,000 Public Offering
12:00am